MIR4737

Across TCGA pan-cancer cohorts, MIR4737 RNA differs between tumor and matched normal tissue in 12 of 18 cancer types tested, making tumor–normal expression one of MIR4737’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where MIR4737 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types MIR4737 is over-expressed in tumor.

KIRC, KIRP, and HNSC are the cancer types where MIR4737 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MIR4737 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	All	All	+0.481	<.001	9	view →
KIRP	All	III,IV	+1.396	<.001	8	view →
HNSC	Male	IV	+0.933	.004	8	view →
LIHC	All	All	+0.548	<.001	5	view →
COAD	Female	All	+1.952	.001	4	view →
BRCA	All	III,IV	+0.771	.003	4	view →
READ	Male	All	+1.576	.009	3	view →
ESCA	All	All	+0.980	.023	3	view →
BLCA	All	All	+0.669	.019	3	view →
LUSC	All	All	+0.423	.004	3	view →
CHOL	All	All	+1.108	.006	2	view →
STAD	Male	II,III,IV	+0.657	.041	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 12 strongest of 12 lineages.

MIR4737–KIRC

Open the KIRC breakdown →